Skip to main content

Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System

A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer

Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

DORAYA-HF Early Feasibility Study

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about DORAYA-HF Early Feasibility Study

Citadel Embolization Device Study

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Citadel Embolization Device Study

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy

STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • Page 47
  • …
  • Next page Next
  • Last page Last
Subscribe to